Komori
Share Issuance and Disposal6232ACSL Ltd.Machinery

Notice Regarding Completion of the Exercise of the 2025 Series 2 to Series 7 Stock Acquisition Rights

All of the 2025 2nd through 7th Series Stock Acquisition Rights were exercised, completing the issuance of new shares and approximately ¥1.6 billion in fundraising.

Worth reading
72In focus
Scored from 2 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
1600000000
Japanese yen (approx.)
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Completion of the exercise of the 2025 2nd through 7th Series Stock Acquisition Rights

発行・処分する株式数

Total of 1,537,000 shares (282,900 shares for the 2nd Series, 188,600 shares for the 3rd Series, 314,100 shares for the 4th Series, 209,400 shares for the 5th Series, 325,200 shares for the 6th Series, and 216,800 shares for the 7th Series)

Intended allottee
Cantor Fitzgerald Europe(CFE)
Amount of funds to be raised

Total of ¥1,641,850,446 (¥302,442,732 for the 2nd Series, ¥245,034,778 for the 3rd Series, ¥302,277,276 for the 4th Series, ¥244,947,744 for the 5th Series, ¥302,153,076 for the 6th Series, and ¥244,994,840 for the 7th Series). The breakdown of the total payment amount and the estimated net proceeds is Not disclosed

Terms of the stock acquisition rights
Number of Stock Acquisition Rights
Total number issued: 15,370 (2,829 for the 2nd Series, 1,886 for the 3rd Series, 3,141 for the 4th Series, 2,094 for the 5th Series, 3,252 for the 6th Series, and 2,168 for the 7th Series). Unexercised balance: 0
Most recent equity financing
3 September 2025: 2025 2nd and 3rd Series Stock Acquisition Rights, total funds raised of ¥547,477,510; 22 September 2025: 2025 4th and 5th Series Stock Acquisition Rights, total funds raised of ¥547,225,020; 14 October 2025: 2025 6th and 7th Series Stock Acquisition Rights, total funds raised of ¥547,147,916
Details of issuance or disposal
ItemDetails
Type of issuance or disposalCompletion of the exercise of the 2025 2nd through 7th Series Stock Acquisition Rights
Number of shares to be issued or disposed ofTotal of 1,537,000 shares (282,900 shares for the 2nd Series, 188,600 shares for the 3rd Series, 314,100 shares for the 4th Series, 209,400 shares for the 5th Series, 325,200 shares for the 6th Series, and 216,800 shares for the 7th Series)
Amount of funds to be raisedTotal of ¥1,641,850,446 (¥302,442,732 for the 2nd Series, ¥245,034,778 for the 3rd Series, ¥302,277,276 for the 4th Series, ¥244,947,744 for the 5th Series, ¥302,153,076 for the 6th Series, and ¥244,994,840 for the 7th Series). The breakdown of the total payment amount and the estimated net proceeds is Not disclosed
Intended allotteeCantor Fitzgerald Europe(CFE)
Total number of issued sharesNot disclosed → 19,277,874 shares
Number of Stock Acquisition RightsTotal number issued: 15,370 (2,829 for the 2nd Series, 1,886 for the 3rd Series, 3,141 for the 4th Series, 2,094 for the 5th Series, 3,252 for the 6th Series, and 2,168 for the 7th Series). Unexercised balance: 0
Most recent equity financing3 September 2025: 2025 2nd and 3rd Series Stock Acquisition Rights, total funds raised of ¥547,477,510; 22 September 2025: 2025 4th and 5th Series Stock Acquisition Rights, total funds raised of ¥547,225,020; 14 October 2025: 2025 6th and 7th Series Stock Acquisition Rights, total funds raised of ¥547,147,916
Items this document does not state (21)
Issue price and disposal priceTotal issue valueEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateBasis for determining the amount to be paidExercise priceExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The Company explained that the exercise of all of these Stock Acquisition Rights had been completed, along with fundraising totaling approximately ¥1.6 billion.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding Completion of the Exercise of the 2025 Series 2 to Series 7 Stock Acquisition Rights | ACSL Ltd. (6232) timely disclosure | Komori